Skip to main
ALAB

ALAB Stock Forecast & Price Target

ALAB Analyst Ratings

Based on 17 analyst ratings
Buy
Strong Buy 41%
Buy 41%
Hold 18%
Sell 0%
Strong Sell 0%

Bulls say

Astera Labs Inc reports a positive financial outlook, highlighted by significantly higher revenue and improved gross margins that more than compensated for increased operating expenses. The company's guidance for the upcoming quarter indicates projected revenue of $249 million, marking an 8% quarter-over-quarter increase and an impressive 76.5% year-over-year growth, surpassing prior estimates. Furthermore, the demand for their PCIe Gen 6 products and the solid growth of their Aries and Taurus solutions support a robust expansion in AI infrastructure, positioning Astera Labs as a key player in the rapidly evolving semiconductor industry.

Bears say

Astera Labs Inc's revenue growth heavily relies on the pace of data center infrastructure spending, making it vulnerable to potential macroeconomic slowdowns in capital investment. Additionally, the company's reliance on the U.S. market for the majority of its revenue exposes it to risks associated with regional economic fluctuations. Such dependence on external capital investment and geographic concentration raises concerns about the company's ability to maintain strong financial performance amid adverse economic conditions.

ALAB has been analyzed by 17 analysts, with a consensus rating of Buy. 41% of analysts recommend a Strong Buy, 41% recommend Buy, 18% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Astera Labs Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Astera Labs Inc (ALAB) Forecast

Analysts have given ALAB a Buy based on their latest research and market trends.

According to 17 analysts, ALAB has a Buy consensus rating as of Apr 6, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $197.06, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $197.06, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Astera Labs Inc (ALAB)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.